Publication | Closed Access

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

Hematological MalignancyLymphoid NeoplasiaConventional ChemotherapyAggressive B-cell LymphomaMedicineImmunologyPathologyHigh-dose ChemotherapyImmunotherapyOncologyRadiation Oncology